Literature DB >> 22678845

Safety of the pipeline embolization device in treatment of posterior circulation aneurysms.

T J Phillips1, J D Wenderoth, C C Phatouros, H Rice, T P Singh, L Devilliers, V Wycoco, S Meckel, W McAuliffe.   

Abstract

BACKGROUND AND
PURPOSE: The published results of treating internal carotid artery aneurysms with the PED do not necessarily apply to its use in the posterior circulation because disabling brain stem infarcts can be caused by occlusion of a single perforator. In this multicenter study, we assessed the safety of PED placement in the posterior circulation.
MATERIALS AND METHODS: A prospective case registry was maintained of all posterior circulation aneurysms treated with PEDs at 3 Australian neurointerventional centers during a 27-month period. The objective was to assess the complications and aneurysm occlusion rates associated with posterior circulation PEDs.
RESULTS: Thirty-two posterior circulation aneurysms were treated in 32 patients. No deaths or poor neurologic outcomes occurred. Perforator territory infarctions occurred in 3 (14%) of the 21 patients with basilar artery aneurysms, and in all 3, a single PED was used. Two asymptomatic intracranial hematomas were recorded. No aneurysm rupture or PED thrombosis was encountered. The overall rate of permanent neurologic complications was 9.4% (3/32); all 3 patients had very mild residual symptoms and a good clinical outcome. Aneurysm occlusion was demonstrated in 85% of patients with >6 months of follow-up and 96% of patients with >1 year of follow-up.
CONCLUSIONS: The PED is effective in the treatment of posterior circulation aneurysms that are otherwise difficult or impossible to treat with standard endovascular or surgical techniques, and its safety is similar to that of stent-assisted coiling techniques. A higher clinical perforator infarction rate may be associated with basilar artery PEDs relative to the internal carotid artery.

Entities:  

Mesh:

Year:  2012        PMID: 22678845      PMCID: PMC7965498          DOI: 10.3174/ajnr.A3166

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  27 in total

1.  Pipeline flow-diverter stent for endovascular treatment of intracranial aneurysms: preliminary experience in 20 patients with 27 aneurysms.

Authors:  Boris Lubicz; Laurent Collignon; Gaï Raphaeli; Olivier De Witte
Journal:  World Neurosurg       Date:  2011 Jul-Aug       Impact factor: 2.104

2.  Delayed spontaneous rupture of a posterior inferior cerebellar artery aneurysm following treatment with flow diversion: a clinicopathologic study.

Authors:  M Chow; C McDougall; C O'Kelly; R Ashforth; E Johnson; D Fiorella
Journal:  AJNR Am J Neuroradiol       Date:  2011-08-11       Impact factor: 3.825

3.  Flow diverters at and beyond the level of the circle of willis for the treatment of intracranial aneurysms.

Authors:  Silvia Pistocchi; Raphaël Blanc; Bruno Bartolini; Michel Piotin
Journal:  Stroke       Date:  2012-01-26       Impact factor: 7.914

4.  The role of the pipeline embolization device for the treatment of dissecting intracranial aneurysms.

Authors:  M de Barros Faria; R Nella Castro; J Lundquist; E Scrivano; R Ceratto; A Ferrario; P Lylyk
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-01       Impact factor: 3.825

5.  Endovascular treatment of posterior circulation fusiform aneurysms: single-center experience in 31 patients.

Authors:  Guy Raphaeli; Laurent Collignon; Olivier De Witte; Boris Lubicz
Journal:  Neurosurgery       Date:  2011-08       Impact factor: 4.654

6.  Immediate and midterm results following treatment of unruptured intracranial aneurysms with the pipeline embolization device.

Authors:  W McAuliffe; V Wycoco; H Rice; C Phatouros; T J Singh; J Wenderoth
Journal:  AJNR Am J Neuroradiol       Date:  2011-10-06       Impact factor: 3.825

7.  Treatment of intracranial aneurysms by functional reconstruction of the parent artery: the Budapest experience with the pipeline embolization device.

Authors:  I Szikora; Z Berentei; Z Kulcsar; M Marosfoi; Z S Vajda; W Lee; A Berez; P K Nelson
Journal:  AJNR Am J Neuroradiol       Date:  2010-02-11       Impact factor: 3.825

8.  Mural destabilization after aneurysm treatment with a flow-diverting device: a report of two cases.

Authors:  Timothy Hampton; Donal Walsh; Christos Tolias; David Fiorella
Journal:  J Neurointerv Surg       Date:  2011-03-01       Impact factor: 5.836

9.  Neuroform stent assisted aneurysm treatment: evolving treatment strategies, complications and results of long term follow-up.

Authors:  D Fiorella; F C Albuquerque; H Woo; P A Rasmussen; T J Masaryk; C G McDougall
Journal:  J Neurointerv Surg       Date:  2009-09-15       Impact factor: 5.836

10.  Stent-assisted coiling of intracranial aneurysms: clinical and angiographic results in 216 consecutive aneurysms.

Authors:  Michel Piotin; Raphaël Blanc; Laurent Spelle; Charbel Mounayer; Rhelen Piantino; Paul J Schmidt; Jacques Moret
Journal:  Stroke       Date:  2009-12-03       Impact factor: 7.914

View more
  59 in total

Review 1.  Endovascular treatment of cerebral aneurysms using flow-diverter devices: A systematic review.

Authors:  Francesco Briganti; Giuseppe Leone; Mariano Marseglia; Giuseppe Mariniello; Ferdinando Caranci; Arturo Brunetti; Francesco Maiuri
Journal:  Neuroradiol J       Date:  2015-08-27

2.  The FRED flow-diverter stent for intracranial aneurysms: clinical study to assess safety and efficacy.

Authors:  M A Möhlenbruch; C Herweh; L Jestaedt; S Stampfl; S Schönenberger; P A Ringleb; M Bendszus; M Pham
Journal:  AJNR Am J Neuroradiol       Date:  2015-02-26       Impact factor: 3.825

3.  Y-crossing of braided stents with stents and flow diverters does not cause significant stenosis in bench-top studies.

Authors:  Alina Makoyeva; Tim E Darsaut; Igor Salazkin; Jean Raymond
Journal:  Interv Neuroradiol       Date:  2013-12-18       Impact factor: 1.610

4.  Periprocedural safety of Pipeline therapy for unruptured cerebral aneurysms: Analysis of 279 Patients in a multihospital database.

Authors:  Robert J McDonald; Jennifer S McDonald; David F Kallmes; Giuseppe Lanzino; Harry J Cloft
Journal:  Interv Neuroradiol       Date:  2015-02       Impact factor: 1.610

5.  Risk of Branch Occlusion and Ischemic Complications with the Pipeline Embolization Device in the Treatment of Posterior Circulation Aneurysms.

Authors:  N Adeeb; C J Griessenauer; A A Dmytriw; H Shallwani; R Gupta; P M Foreman; H Shakir; J Moore; N Limbucci; S Mangiafico; A Kumar; C Michelozzi; Y Zhang; V M Pereira; C C Matouk; M R Harrigan; A H Siddiqui; E I Levy; L Renieri; T R Marotta; C Cognard; C S Ogilvy; A J Thomas
Journal:  AJNR Am J Neuroradiol       Date:  2018-06-07       Impact factor: 3.825

6.  Current Strategies in the Treatment of Intracranial Large and Giant Aneurysms.

Authors:  Matthias Gmeiner; Andreas Gruber
Journal:  Acta Neurochir Suppl       Date:  2021

7.  Flow Diversion for Intracranial Aneurysm Management: A New Standard of Care.

Authors:  Fawaz Al-Mufti; Krishna Amuluru; Chirag D Gandhi; Charles J Prestigiacomo
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

8.  Super-selective coil embolization of a basilar perforator artery aneurysm previously treated by the stent-in-stent technique, using an extremely soft bare coil delivered through a one-marker microcatheter.

Authors:  Yves Chau; Marina Sachet; Jacques Sédat
Journal:  Interv Neuroradiol       Date:  2017-07-20       Impact factor: 1.610

9.  Hemodynamic differences by increasing low profile visualized intraluminal support (LVIS) stent local compaction across intracranial aneurysm orifice.

Authors:  Zhongbin Tian; Mingqi Zhang; Gaohui Li; Rongbo Jin; Xiaochang Leng; Ying Zhang; Kun Wang; Yisen Zhang; Xinjian Yang; Jianping Xiang; Jian Liu
Journal:  Interv Neuroradiol       Date:  2020-08-23       Impact factor: 1.610

10.  Retrograde trans-anterior communicating artery rescue of unopened Pipeline Embolization Device with balloon dilation: complication management.

Authors:  Ramon Navarro; Jang Yoon; Tanya Dixon; David A Miller; Ricardo A Hanel; Rabih G Tawk
Journal:  BMJ Case Rep       Date:  2014-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.